Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study

1. Murray, M.
2. Pulido, F.
3. Mills, A.
4. Ramgopal, M.
5. LeBlanc, R.
6. Jaeger, H.
7. Canon, V.
8. Dorey, D.
9. Griffith, S.
10. Mrus, J.
11. Spreen, W.
12. Margolis, D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1080/25787489.2019.1661696 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus